Since July 9, the Ticovac 0.25 ml children’s vaccine from the Pfizer laboratory has been out of stock. Recommended for certain trips, the vaccine prevents tick-borne encephalitis. The National Agency for Safety and Medicines (ansm) announces this out of stock on its site. This should last until the end of July at the earliest, according to the agency. A “contingent release [est] scheduled from the week of July 30”, further specifies the ANSM.
Tick-borne encephalitis is a viral disease caused by a virus (arbovirus) transmitted to humans by the tick bite infected. After an incubation period of one to two weeks, the disease develops suddenly with the first flu-like symptoms, accompanied by fever, headaches and chills.
The vaccine against tick-borne encephalitis is recommended for adults and children over 1 year old when full stays are planned in areas where the disease is present (central, eastern and northern Europe, northern Europe). Asia, northern China, northern Japan). Travelers who must reside in rural or wooded areas of the affected regions, from spring to autumn, are encouraged to be vaccinated to reduce the risk of contracting the disease, reports the vaccination-info-service site.
Few cases of tick-borne encephalitis in France
Between 5,000 and 13,000 cases of tick-borne encephalitis are reported worldwide each year. Tick-borne encephalitis remains very rare in France. It currently rages from Eastern Europe, to northern Japan and China.
In addition to vaccines, wearing closed shoes and covering clothing possibly impregnated with repellents is one of the good reflexes to have for protect yourself from ticks. A smartphone application, Tick reporting, to indicate the presence of ticks to walkers is also available.
[#EtéSansSouci☀] Our advice to avoid summer stings and bites and the right reflexes to react to them https://t.co/hXESBxu9Fd
—ANSM (@ansm) July 16, 2018
Read also
Why mosquitoes bite en masse this summer
In Toulouse the war against the tiger mosquito is declared
